Kreijtz JHCM - Search Results

1

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.

de Vries RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, van Trierum SE, Pronk MR, Lamers MM, Richard M, Nieuwenhuijse DF, Koopmans MPG, Kreijtz JHCM, Fouchier RAM, Osterhaus ADME, Sutter G, Rimmelzwaan GF. de Vries RD, et al. Among authors: kreijtz jhcm. J Infect Dis. 2018 Jul 13;218(4):614-623. doi: 10.1093/infdis/jiy214. J Infect Dis. 2018. PMID: 29912453 Free PMC article. Clinical Trial.

2

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. J Infect Dis. 2007 Jun 1;195(11):1598-606. doi: 10.1086/517614. Epub 2007 Apr 17. J Infect Dis. 2007. PMID: 17471429

3

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF. Kreijtz JH, et al. Hum Vaccin. 2009 Mar;5(3):126-35. doi: 10.4161/hv.5.3.6986. Epub 2009 Mar 15. Hum Vaccin. 2009. PMID: 18948744 Review.

4

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, van den Brand JM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Bodewes R, et al. PLoS One. 2009;4(5):e5538. doi: 10.1371/journal.pone.0005538. Epub 2009 May 14. PLoS One. 2009. PMID: 19440239 Free PMC article.

5

Yearly influenza vaccinations: a double-edged sword?

Bodewes R, Kreijtz JH, Rimmelzwaan GF. Bodewes R, et al. Lancet Infect Dis. 2009 Dec;9(12):784-8. doi: 10.1016/S1473-3099(09)70263-4. Epub 2009 Oct 30. Lancet Infect Dis. 2009. PMID: 19879807

6

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

Kreijtz JH, Suezer Y, de Mutsert G, van Amerongen G, Schwantes A, van den Brand JM, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. PLoS One. 2009 Nov 12;4(11):e7790. doi: 10.1371/journal.pone.0007790. PLoS One. 2009. PMID: 19915662 Free PMC article.

7

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.

Bodewes R, Kreijtz JH, Hillaire ML, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Bodewes R, et al. J Gen Virol. 2010 Jul;91(Pt 7):1743-53. doi: 10.1099/vir.0.020784-0. Epub 2010 Mar 24. J Gen Virol. 2010. PMID: 20335492

8

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.

Kreijtz JH, Süzer Y, Bodewes R, Schwantes A, van Amerongen G, Verburgh RJ, de Mutsert G, van den Brand J, van Trierum SE, Kuiken T, Fouchier RA, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. J Gen Virol. 2010 Nov;91(Pt 11):2745-52. doi: 10.1099/vir.0.024885-0. Epub 2010 Aug 18. J Gen Virol. 2010. PMID: 20719991

9

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.

Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A. Altenburg AF, et al. Viruses. 2014 Jul 17;6(7):2735-61. doi: 10.3390/v6072735. Viruses. 2014. PMID: 25036462 Free PMC article. Review.

10

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.

van de Sandt CE, Kreijtz JH, Geelhoed-Mieras MM, Vogelzang-van Trierum SE, Nieuwkoop NJ, van de Vijver DA, Fouchier RA, Osterhaus AD, Morein B, Rimmelzwaan GF. van de Sandt CE, et al. Vaccine. 2014 Sep 29;32(43):5614-23. doi: 10.1016/j.vaccine.2014.08.003. Epub 2014 Aug 17. Vaccine. 2014. PMID: 25140929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page